日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A new Jun amino-terminal kinase inhibitor, KRev-202, inhibits rat ischemic acute injury and the progression to renal fibrosis

一种新型的Jun氨基末端激酶抑制剂KRev-202可抑制大鼠缺血性急性损伤及其向肾纤维化的进展。

Nikolic-Paterson, David J; Tesch, Greg H; Ozols, Elyce; Jarnagin, Kurt; Satoh, Yoshi; Webb, David R; Squiers, Elizabeth; Grynberg, Keren; Ma, Frank Y

Animal models for SARS-Cov2/Covid19 research-A commentary

用于SARS-CoV-2/COVID-19研究的动物模型——评述

Jarnagin, Kurt; Alvarez, Oscar; Shresta, Sujan; Webb, David R

Clinical trial design for cutaneous neurofibromas

皮肤神经纤维瘤的临床试验设计

Cannon, Ashley; Jarnagin, Kurt; Korf, Bruce; Widemann, Brigitte C; Casey, Denise; Ko, Hon-Sum; Blakeley, Jaishri O; Verma, Sharad K; Pichard, Dominique C

Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.

环核苷酸磷酸二酯酶 4 (PDE4) 作为潜在驱虫药物靶点的表型、化学和功能表征

Long Thavy, Rojo-Arreola Liliana, Shi Da, El-Sakkary Nelly, Jarnagin Kurt, Rock Fernando, Meewan Maliwan, Rascón Alberto A Jr, Lin Lin, Cunningham Katherine A, Lemieux George A, Podust Larissa, Abagyan Ruben, Ashrafi Kaveh, McKerrow James H, Caffrey Conor R